BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 14612427)

  • 1. Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway.
    Zhang Y; Wolf GW; Bhat K; Jin A; Allio T; Burkhart WA; Xiong Y
    Mol Cell Biol; 2003 Dec; 23(23):8902-12. PubMed ID: 14612427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of HDM2 activity by the ribosomal protein L11.
    Lohrum MA; Ludwig RL; Kubbutat MH; Hanlon M; Vousden KH
    Cancer Cell; 2003 Jun; 3(6):577-87. PubMed ID: 12842086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5.
    Dai MS; Lu H
    J Biol Chem; 2004 Oct; 279(43):44475-82. PubMed ID: 15308643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of HDM2 and activation of p53 by ribosomal protein L23.
    Jin A; Itahana K; O'Keefe K; Zhang Y
    Mol Cell Biol; 2004 Sep; 24(17):7669-80. PubMed ID: 15314174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stress.
    Bursać S; Brdovčak MC; Pfannkuchen M; Orsolić I; Golomb L; Zhu Y; Katz C; Daftuar L; Grabušić K; Vukelić I; Filić V; Oren M; Prives C; Volarevic S
    Proc Natl Acad Sci U S A; 2012 Dec; 109(50):20467-72. PubMed ID: 23169665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perturbation of 60 S ribosomal biogenesis results in ribosomal protein L5- and L11-dependent p53 activation.
    Sun XX; Wang YG; Xirodimas DP; Dai MS
    J Biol Chem; 2010 Aug; 285(33):25812-21. PubMed ID: 20554519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical and functional interaction between ribosomal protein L11 and the tumor suppressor ARF.
    Dai MS; Challagundla KB; Sun XX; Palam LR; Zeng SX; Wek RC; Lu H
    J Biol Chem; 2012 May; 287(21):17120-17129. PubMed ID: 22467867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the MDM2-p53 pathway by ribosomal protein L11 involves a post-ubiquitination mechanism.
    Dai MS; Shi D; Jin Y; Sun XX; Zhang Y; Grossman SR; Lu H
    J Biol Chem; 2006 Aug; 281(34):24304-13. PubMed ID: 16803902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperation between the ribosomal proteins L5 and L11 in the p53 pathway.
    Horn HF; Vousden KH
    Oncogene; 2008 Oct; 27(44):5774-84. PubMed ID: 18560357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation.
    Ghosh M; Huang K; Berberich SJ
    Biochemistry; 2003 Mar; 42(8):2291-9. PubMed ID: 12600196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition.
    Dai MS; Zeng SX; Jin Y; Sun XX; David L; Lu H
    Mol Cell Biol; 2004 Sep; 24(17):7654-68. PubMed ID: 15314173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation.
    Lindström MS; Jin A; Deisenroth C; White Wolf G; Zhang Y
    Mol Cell Biol; 2007 Feb; 27(3):1056-68. PubMed ID: 17116689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribosomal stress induces L11- and p53-dependent apoptosis in mouse pluripotent stem cells.
    Morgado-Palacin L; Llanos S; Serrano M
    Cell Cycle; 2012 Feb; 11(3):503-10. PubMed ID: 22262176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depletion of ribosomal protein L37 occurs in response to DNA damage and activates p53 through the L11/MDM2 pathway.
    Llanos S; Serrano M
    Cell Cycle; 2010 Oct; 9(19):4005-12. PubMed ID: 20935493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the HDM2-p53 pathway by ribosomal protein L6 in response to ribosomal stress.
    Bai D; Zhang J; Xiao W; Zheng X
    Nucleic Acids Res; 2014 Feb; 42(3):1799-811. PubMed ID: 24174547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative regulation of HDM2 to attenuate p53 degradation by ribosomal protein L26.
    Zhang Y; Wang J; Yuan Y; Zhang W; Guan W; Wu Z; Jin C; Chen H; Zhang L; Yang X; He F
    Nucleic Acids Res; 2010 Oct; 38(19):6544-54. PubMed ID: 20542919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein.
    Roth J; Dobbelstein M; Freedman DA; Shenk T; Levine AJ
    EMBO J; 1998 Jan; 17(2):554-64. PubMed ID: 9430646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essential role of ribosomal protein L11 in mediating growth inhibition-induced p53 activation.
    Bhat KP; Itahana K; Jin A; Zhang Y
    EMBO J; 2004 Jun; 23(12):2402-12. PubMed ID: 15152193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MdmX protects p53 from Mdm2-mediated degradation.
    Jackson MW; Berberich SJ
    Mol Cell Biol; 2000 Feb; 20(3):1001-7. PubMed ID: 10629057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53.
    Tao W; Levine AJ
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):3077-80. PubMed ID: 10077639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.